XRP broke descending resistance, reclaiming $2.45 support. The next challenge is $2.77. A breakout above could trigger a ...

A class action lawsuit was filed against Cassava Sciences Inc. (SAVA) by Levi & Korsinsky on December 12, 2024. The ...

Fears of tighter monetary policy initially sent shockwaves through risk-on assets, prompting sell-offs across various digital ...

Hosted a virtual key opinion leader (KOL) event on November 20, 2024 featuring Abhishek Ray, MD (University Hospitals) and Andrew Webb, PharmD, BCCCP (Massachusetts General Hospital), who discussed ...

Descending channel breakout signals potential bullish momentum. Wave structure aligns with Elliott Wave’s corrective and impulsive phases. Key Fibonacci levels define critical price zones for ...

MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...

Drivers in the City of Redding should be prepared for potential traffic delays as crews begin the next phases of the Athens Area Water Improvement Project.

Dogecoin has found support at $0.22 after a 40% decline, with technical indicators and historical patterns suggesting a ...

King County government agencies have been told to brace for potential cuts due to a projected $150 million budget shortfall ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Eli Lilly has been a terrific stock to own for the past five years, thanks to its excellent clinical and regulatory progress.

Royalty Pharma to provide R&D investment of up to $250 million for Biogen's litifilimab, a potential first-in-class biologic in Phase 3 development for the treatment of lupus. NEW ...